{
  "docId": "019de072-f883-7038-87b7-1190d38538fc",
  "docSlug": "b2613cd3e65595fa61ed3ce545efa4c9",
  "documentTitle": "Exscientia | Investor Presentation Deck | 37 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 32,
  "pageCount": 37,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "overcrowded",
  "nDataPoints": 24,
  "notes": "The slide uses a color-coded heatmap (green/yellow/red) to highlight performance against criteria.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-f883-7038-87b7-1190d38538fc/32",
  "deckHref": "/decks/019de072-f883-7038-87b7-1190d38538fc",
  "deckJsonHref": "/decks/019de072-f883-7038-87b7-1190d38538fc.json",
  "deckAnchorHref": "/decks/019de072-f883-7038-87b7-1190d38538fc#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.28,
        "x": 0.69,
        "y": 0.445
      },
      "kind": "callout",
      "text": "Low potency will require high dosing for efficacy",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11dc2f02-b2d4-42f9-96fc-a5d92a136c24",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.28,
        "x": 0.69,
        "y": 0.58
      },
      "kind": "callout",
      "text": "Efflux concerns for a cell cycle inhibitor: Substantial GI tox, High variability on absorption, Ability to stay in tumor cell",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6507de28-f8aa-4650-85c4-7ae4915d98a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.28,
        "x": 0.69,
        "y": 0.335
      },
      "kind": "callout",
      "text": "Lack of selectivity could lead to systemic toxicity",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c255d749-3925-4f65-9e4d-58b8e9ebd52b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.25,
        "y": 0.845
      },
      "kind": "legend",
      "text": "Meets or Exceeds criteria, Minor deviation, Major deviation",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "deb9096c-3db6-4466-b00c-529ec39b27e3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.65,
        "x": 0.04,
        "y": 0.28
      },
      "kind": "table",
      "text": "Comparison table of Assay, Candidate Criteria, and two competing candidates across Target affinity, Cell potency, Safety, and Permeability.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f54aa570-2fec-4a9b-9c27-901a3b909bf4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.65,
        "x": 0.08,
        "y": 0.14
      },
      "kind": "title",
      "text": "Unable to validate CDK7 mechanism without a clean drug profile",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a343727d-2295-4143-ae95-9f8345c58946",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.08,
        "y": 0.07
      },
      "kind": "title",
      "text": "Design flaws can impact clinical outcomes",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4161a549-c366-4c43-a875-99932aabd9f1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "13e7385f-264e-4252-a564-a1019b36f3d4",
      "evidence": "table/data: Comparison table of Assay, Candidate Criteria, and two competing candidates across Target affinity, Cell potency, Safety, and Permeability.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "evidence-matrix",
      "slug": null,
      "matchId": "8507cc2e-85d4-4caf-b7e5-177288c77f99",
      "evidence": "Comparison of drug candidate performance against clinical criteria",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 35,
      "from": 24,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5c4c8d7b-e37e-409f-8937-2163508fee37",
      "evidence": "The deck presents data on the consequences of traditional drug discovery methods on slides 24-35",
      "position": 0,
      "objective": "Highlight the consequences of not adopting Exscientia's AI-driven approach",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 37,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "7b15f9dd-8590-4693-8bcf-77e7f6a4d27a",
      "evidence": "The deck presents a clear narrative around Exscientia's strategy and its benefits throughout",
      "position": 1,
      "objective": "Explain Exscientia's patient-first AI strategy and its benefits",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}